Development of an ophthalmic solution combining allogenic plasma with protective excipients for enhanced therapeutic role in the management of ocular surface diseases.

Saved in:
Bibliographic Details
Title: Development of an ophthalmic solution combining allogenic plasma with protective excipients for enhanced therapeutic role in the management of ocular surface diseases.
Authors: Roche A; Pharmacy Department, CHU Clermont-Ferrand, F-63003 Clermont-Ferrand, France., Chennell P; Université Clermont Auvergne, CHU Clermont-Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France. Electronic address: pchennell@chu-clermontferrand.fr., Chiambaretta F; Department of Ophthalmology, CHU Clermont-Ferrand F-63000 Clermont-Ferrand, France., Serre-Sapin AF; Université Clermont Auvergne, CHU Clermont-Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France., Wasiak M; Pharmacy Department, CHU Clermont-Ferrand, F-63003 Clermont-Ferrand, France., Bouattour Y; Université Clermont Auvergne, CHU Clermont-Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France., Bailly-De-France V; Biochemistry and Molecular Genetic Department, CHU Clermont-Ferrand F-63000 Clermont-Ferrand, France., Fogli A; Biochemistry and Molecular Genetic Department, CHU Clermont-Ferrand F-63000 Clermont-Ferrand, France., Durif J; Biochemistry and Molecular Genetic Department, CHU Clermont-Ferrand F-63000 Clermont-Ferrand, France., Quinard R; Biochemistry and Molecular Genetic Department, CHU Clermont-Ferrand F-63000 Clermont-Ferrand, France., Jouannet M; Pharmacy Department, CHU Clermont-Ferrand, F-63003 Clermont-Ferrand, France., Sapin V; Biochemistry and Molecular Genetic Department, CHU Clermont-Ferrand F-63000 Clermont-Ferrand, France., Sautou V; Université Clermont Auvergne, CHU Clermont-Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France.
Source: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2025 Sep; Vol. 214, pp. 114813. Date of Electronic Publication: 2025 Jul 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-3441
DOI:10.1016/j.ejpb.2025.114813